La jolla Pharmaceutical
La Jolla Pharmaceutical Company |.
Launch date
Employees
Market cap
AUD239m
Enterprise valuation
AUD240m (Public information from Aug 2022)
Share price
€6.072
San Diego California (HQ)
Financials
Estimates*
USD | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|---|
Revenues | - | - | 10.0m | 23.0m | 33.0m | 76.0m | 56.0m |
% growth | - | - | - | 130 % | 43 % | 130 % | (26 %) |
EBITDA | - | (114m) | - | - | - | - | - |
Profit | - | (115m) | (199m) | (117m) | (39.0m) | 15.0m | - |
% profit margin | - | - | (1990 %) | (509 %) | (118 %) | 20 % | - |
EV / revenue | - | - | 7.4x | 4.7x | 3.2x | 1.5x | 2.0x |
EV / EBITDA | - | -5.5x | - | - | - | - | - |
R&D budget | 64.9m | 78.1m | 112m | 79.2m | - | - | - |
R&D % of revenue | - | - | 1122 % | 344 % | - | - | - |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
N/A | $5.2m | Early VC | |
N/A | $17.8m | Post IPO Equity | |
* | N/A | Acquisition | |
Total Funding | AUD8.0m |
Related Content
Recent News about La jolla Pharmaceutical
EditInvestments by La jolla Pharmaceutical
EditACQUISITION by La jolla Pharmaceutical Jul 2020